Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Amato, Marco C ^a   Giordano, Carla ^a   Pitrone, Maria ^a   Galluzzo, Aldo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

cardiometabolic risk; Obesity; VAI; visceral adipose dynsfunction

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK; WAIST CIRCUMFERENCE; CROSS-SECTIONAL STUDY; ETHNOLOGY; MIDDLE AGED; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PREVALENCE; REFERENCE VALUE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY WEIGHTS AND MEASURES; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; SICILY; YOUNG ADULT;

EID: 80054119076     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-183     Document Type: Article

References (27)

1. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. Beckley ET, DOC News 2006 3 1 3
2. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Eckel RH, Kahn R, Robertson RM, Rizza RA, Circulation 2006 113 2943 2946 10.1161/CIRCULATIONAHA.106.176583 16801475 (Pubitemid 44297236)
3. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? Lemieux I, Arterioscler Thromb Vasc Biol 2004 24 795 797 10.1161/01.ATV.0000126485.80373.33 15132969 (Pubitemid 38620852)
4. Waist circumference and abdominal saggital diameter: best simple anthropometric indices of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ, Am J Cardiol 1994 73 460 468 10.1016/0002-9149(94)90676-9 8141087 (Pubitemid 24096208)
5. Visceral obesity and the heart. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP, Int J Biochem Cell Biol 2008 40 821 826 10.1016/j.biocel.2007.12.001 18201922
6. High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent: A Determinant of an Adverse Metabolic Phenotype. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R, Diabetes 2008 57 367 371 17977954
7. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH, Am J Physiol Endocrinol Metab 2000 278 941 948 10780952
8. Is visceral obesity the cause of the metabolic syndrome? Despres JP, Ann Med 2006 38 52 63 10.1080/07853890500383895 16448989 (Pubitemid 43177788)
9. Adipose tissue as an endocrine organ. Kershaw EE, Flier JS, J Clin Endocrinol Metab 2004 89 2548 2556 10.1210/jc.2004-0395 15181022 (Pubitemid 38766330)
10. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, AlkaMeSy Study Group, Diabetes Care 2010 33 920 922 10.2337/dc09-1825 20067971
11. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Bozorgmanesh M, Hadaegh F, Azizi F, Lipids Health Dis 2011 10 88 10.1186/1476-511X-10-88 21619588
12. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Petta S, Amato M, Cabibi D, Camm C, Di Marco V, Giordano C, Galluzzo A, Crax A, Hepatology 2010 52 1543 1552 10.1002/hep.23859 20799355
13. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. Amato MC, Verghi M, Galluzzo A, Giordano C, Hum Reprod 2011 26 1486 1494 10.1093/humrep/der088 21447694
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 1997 20 1183 1197 9203460
15. Guidelines for the management of arterial hypertension. European Society of Hypertension-European Society of Cardiology, J Hypertens 2003 21 1011 1053 12777938
16. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
17. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 461 470 10075613 (Pubitemid 29135798)
18. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ, Circulation 2007 116 39 48 10.1161/CIRCULATIONAHA.106.675355 17576866 (Pubitemid 47016245)
19. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R, Diabetes 2008 57 367 371 17977954
20. Abdominal subcutaneous adipose tissue: a protective fat depot? Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS, Diabetes Care 2009 32 1068 1075 10.2337/dc08-2280 19244087
21. Visceral obesity and the heart. Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP, Int J Biochem Cell Biol 2008 40 821 836 10.1016/j.biocel.2007.12.001 18201922
22. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH, Am J Physiol Endocrinol Metab 2000 278 941 948 10780952
23. Is visceral obesity the cause of the metabolic syndrome? Despres JP, Ann Med 2006 38 52 63 10.1080/07853890500383895 16448989 (Pubitemid 43177788)
24. The individual components of the metabolic syndrome: is there a raison d'etre? Reaven GM, J Am Coll Nutr 2007 26 191 195 17634163 (Pubitemid 47134700)
25. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Klein BE, Klein R, Lee KE, Diabetes Care 2002 25 1790 1794 10.2337/diacare.25.10.1790 12351479 (Pubitemid 41071088)
26. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP, Am J Clin Nutr 1993 58 463 467 8379501 (Pubitemid 23307401)
27. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Unger RH, Scherer PE, Trends Endocrinol Metab 2010 21 345 352 10.1016/j.tem.2010.01.009 20223680